...
首页> 外文期刊>Cancer Cell >Cooperative epigenetic modulation by cancer amplicon genes.
【24h】

Cooperative epigenetic modulation by cancer amplicon genes.

机译:癌症扩增子基因的协同表观遗传调控。

获取原文
获取原文并翻译 | 示例
           

摘要

Chromosome band 9p24 is frequently amplified in primary mediastinal B cell lymphoma (PMBL) and Hodgkin lymphoma (HL). To identify oncogenes in this amplicon, we screened an RNA interference library targeting amplicon genes and thereby identified JAK2 and the histone demethylase JMJD2C as essential genes in these lymphomas. Inhibition of JAK2 and JMJD2C cooperated in killing these lymphomas by decreasing tyrosine 41 phosphorylation and increasing lysine 9 trimethylation of histone H3, promoting heterochromatin formation. MYC, a major target of JAK2-mediated histone phosphorylation, was silenced after JAK2 and JMJD2C inhibition, with a corresponding increase in repressive chromatin. Hence, JAK2 and JMJD2C cooperatively remodel the PMBL and HL epigenome, offering a mechanistic rationale for the development of JAK2 and JMJD2C inhibitors in these diseases.
机译:染色体带9p24在原发性纵隔B细胞淋巴瘤(PMBL)和霍奇金淋巴瘤(HL)中经常扩增。为了鉴定该扩增子中的癌基因,我们筛选了靶向扩增子基因的RNA干扰文库,从而鉴定出JAK2和组蛋白脱甲基酶JMJD2C是这些淋巴瘤中的必需基因。 JAK2和JMJD2C的抑制作用通过减少组蛋白H3的酪氨酸41磷酸化和增加赖氨酸9三甲基化,促进异染色质的形成来杀死这些淋巴瘤。 MYC是JAK2介导的组蛋白磷酸化的主要靶点,在抑制JAK2和JMJD2C后,沉默了染色质,从而使沉默沉默。因此,JAK2和JMJD2C共同重塑了PMBL和HL表观基因组,为开发这些疾病中的JAK2和JMJD2C抑制剂提供了机械原理。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号